Institutional members access full text with Ovid®

Vascular Access and Contrast Media

Earhart, Ann MSN, ACNS-BC, CRNI®; McMahon, Paula BS, RN, CRNI®, CRN

doi: 10.1097/NAN.0b013e31820b4a11
Features

Over the past several years, the Food and Drug Administration (FDA) has received more than 250 adverse event reports in which vascular access devices have ruptured when used with power injectors. The adverse events include rupture and device fragmentation. The outcome of these events affects both the patient and the care provider.

Banner Health, Banner Good Samaritan Medical Center, Phoenix, Arizona.

Correspondence: Ann Earhart, MSN, ACNS-BC, CRNI®, Banner Good Samaritan Medical Center, 1111 12th St, Phoenix, AZ 85006 (ann.earhart@bannerhealth.com).

Ann Earhart is a Clinical Nurse Specialist employed by Banner Good Samaritan Medical Center in Phoenix, Arizona.

Paula McMahon has certifications in both Infusion Therapy and Radiology Nursing. She currently works for the Medical Surgical Division of BD Medical, specializing in infusion therapy products.

© Copyright 2011 by the Infusion Nurses Society